Reply to: "To conclude that BNT162b2 does not worsen echocardiographic indices, well-powered multicenter studies are required"
J Chin Med Assoc
.
2024 Feb 1;87(2):243.
doi: 10.1097/JCMA.0000000000001048.
Epub 2023 Dec 25.
Authors
Wan-Fu Hsu
1
2
,
Chih-Hsiung Hsu
3
4
,
Mei-Jy Jeng
2
5
6
Affiliations
1
Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
2
Institute of Emergency and Critical Care Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
3
School of Public Health, National Defense Medical Center, Taipei, Taiwan, ROC.
4
Health Service and Readiness Section, Armed Forces Taoyuan General Hospital, Taoyuan, Taiwan, ROC.
5
Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
6
Department of Pediatrics, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
PMID:
38145399
DOI:
10.1097/JCMA.0000000000001048
No abstract available
MeSH terms
BNT162 Vaccine*
Echocardiography*
Humans
Substances
BNT162 Vaccine